Physician profile
Ga-Ram Han
NPI 1891299376
$8,647.42
in general payments reported to CMS, 2019-2025
11 companies · $1,449 in 2025
The $1,449 reported for 2025 was more than what 78% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2022: $1,006 · 2023: $3,986 · 2024: $2,072 · 2025: $1,449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,352 · Education: $2,500 · Food and Beverage: $1,656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,351.86 |
| Education | $2,500.00 |
| Food and Beverage | $1,656.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,990.77 | 2022-2024 | Davinci Xi, Da Vinci Surgical System, Da Vinci Sp |
| Medtronic, INC. | $942.29 | 2023-2024 | Interstim |
| Thd America, INC. | $854.86 | 2025 | |
| Boston Scientific Corporation | $613.32 | 2024-2025 | Axonics |
| Applied Medical Resources Corporation | $557.72 | 2023 | Gelport Laparoscopic System |
| Axonics, INC. | $337.59 | 2024 | Axonics |
| Baxter Healthcare | $134.20 | 2023-2025 | Floseal, Tisseel |
| Allergan, INC. | $132.80 | 2019 | |
| Davol INC. | $30.50 | 2025 | Phasix Mesh |
| Ethicon US, LLC | $30.30 | 2025 | Echelon Circular |
| Takeda Pharmaceuticals U.S.A., INC. | $23.07 | 2024 | Gattex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ga-Ram Han listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.